A live-in residency for cell, gene, and longevity founders — built inside the Kobe Biomedical Innovation Cluster and the world's most accelerated regenerative-medicine market.
CELL THERAPYATGCCATTGGACCTTAAGCGGENE THERAPYATGCCATTGGACCTTAAGCGREGENERATIVE MEDICINEATGCCATTGGACCTTAAGCGiPS CELLSATGCCATTGGACCTTAAGCGKOBE · PORT ISLANDATGCCATTGGACCTTAAGCGLONGEVITYATGCCATTGGACCTTAAGCGCELL THERAPYATGCCATTGGACCTTAAGCGGENE THERAPYATGCCATTGGACCTTAAGCGREGENERATIVE MEDICINEATGCCATTGGACCTTAAGCGiPS CELLSATGCCATTGGACCTTAAGCGKOBE · PORT ISLANDATGCCATTGGACCTTAAGCGLONGEVITYATGCCATTGGACCTTAAGCG
The node · CellHaus
Allogeneic cell & gene therapy
Kobe is not a backdrop — it is the accelerant. The city pairs the deepest regenerative-medicine cluster in Asia with the fastest path from bench to approved product anywhere on earth.
T
Terrain
The Kobe Biomedical Innovation Cluster: 334 members, roughly 12,700 staff, 8 hospitals and 1,500 beds on a single island.
R
Regulation
Japan's conditional and time-limited approval lets cell therapies reach market on early-stage data — years ahead of the FDA or EMA.
N
Network
RIKEN BDR, FBRI's PIC/S-GMP cell-manufacturing center, and the lineage of the world's first iPS-cell transplant.
C
Capital
AMED non-dilutive grants, a registered VC co-invest network, and Kobe operating costs roughly half of Tokyo.
CellHaus
Why Japan, why now
01
Born here
iPS-cell technology originated in Japan — Yamanaka, Kyoto, 2006; Nobel Prize 2012. The science, talent, and institutions are home-grown.
02
World firsts
In 2014 a RIKEN/Kobe team performed the world's first transplant of iPS-derived tissue into a human, at Kobe City Medical Center.
03
2026 inflection
On 6 March 2026, Japan approved its first two iPS-cell therapies on the same day — for Parkinson's and for heart failure.
04
Aligned market
The world's most aged society creates urgent demand, and regenerative medicine has been national strategy since the early 2000s.
Program
The founder journey
One cohort, three phases — recruit, build in Kobe, then showcase across Tokyo and San Francisco.
Recruit
Jul – Aug 2026
Applications open · cohort selected
Build in Kobe
Sep – Oct 2026
Orientation in Kobe · BioJapan, Yokohama · Mirai City events on Port Island · Demo Day, Tokyo
Showcase & scale
Nov – Dec 2026
Health Longevity & Medicine Conference and showcase, Tokyo · showcase, San Francisco
CellHaus · Kobe, Japan
Build where it gets approved.
CellHaus opens on Port Island in September 2026. Founders, mentors, partners, and sponsors — get in touch.